Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · International Stock · Lazard

Lazard International Equity Portfolio R6 Shares (RLIEX)

Ticker RLIEX · Since 2015-04-01 · · Holdings as of Jun 30, 2026

Expense ratio
0.8%$80/yr per $10k
5-yr return
+8.4%annualized
1-yr return
+34.1%as of Dec 2025
Net assets
$1.3Ball share classes
Holdings
78

Bottom line

Is RLIEX a good fund? The bottom line

RLIEX is the R6 share class of Lazard International Equity Portfolio, a managed international stock mutual fund from Lazard.

Its expense ratio is 0.8% — about $80 a year on every $10,000 invested, cheaper than 62% of international stock funds we track.

It returned +34.1% over one year, +8.4% a year over five years, +7.2% a year over ten (as of Dec 31, 2025, per its prospectus).

With $1.3 billion in net assets and 78 holdings, its largest position is Lazard Govt Mny Mmkt Ins (4.5%) and the top 10 make up 22.8% of the portfolio.

Updated Nov 19, 2026

What RLIEX invests in

The Portfolio seeks long-term capital appreciation.

Under normal circumstances, the Portfolio invests at least 80% of its assets in equity securities. Equity security investments primarily include common stocks and also may include American Depositary Receipts, Global Depositary Receipts and European Depositary Receipts. The Portfolio invests primarily in equity securities of relatively large non-U.S. companies with market capitalizations in the range of companies included in the MSCI Europe, Australasia and Far East (EAFE ) Index (ranging from approximately $3.5 billion to $500.5 billion as of March 31, 2026) that the Investment Manager believes are undervalued based on their earnings, cash flow or asset values. In choosing stocks for the Portfolio, the Investment Manager looks for established companies in economically developed countries and may invest up to 15% of the Portfolios assets in securities of companies whose principal…

From the fund's prospectus (filed Apr 23, 2026).

RLIEX performance

Average annual total returns
1 yr5 yr10 yr
RLIEX+34.1%+8.4%+7.2%
International Stock median+25.5%+6.4%+7.6%

Source: Fund prospectus, as of Dec 31, 2025

Full RLIEX performance history →

What RLIEX costs

On a $10,000 investment, RLIEX's 0.8% expense ratio costs about $80 a year. The prospectus estimates $1,023 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.

See the full RLIEX fee table →

RLIEX top 10 holdings

#Holding% of fund
1Lazard Govt Mny Mmkt Ins4.45%
2Engie SA2.48%
3Unilever PLC2.29%
4Banco Santander SA2.23%
5AstraZeneca PLC2.13%
6AIA Group Ltd1.96%
7Relx Plc1.91%
8Samsung Electronics Co Ltd1.89%
9National Bank of Greece SA1.78%
10Shimadzu Corp1.72%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 22.8% of the fund. See all top 25 holdings and asset mix →

Alternatives to RLIEX

More funds like RLIEX →

RLIEX FAQ

What is the expense ratio of RLIEX?
RLIEX's expense ratio is 0.8%, which works out to about $80 a year for every $10,000 invested. The prospectus estimates total costs of $1,023 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is RLIEX a good investment?
It depends on your goals, but the data points to: a typical fund for its category. This is general information, not personalized advice.
What does RLIEX hold?
RLIEX's largest holdings are Lazard Govt Mny Mmkt Ins (4.5%), Engie SA (2.5%), Unilever PLC (2.3%), Banco Santander SA (2.2%), AstraZeneca PLC (2.1%). It holds 78 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is RLIEX's 5-year return?
RLIEX returned +8.4% a year over the five years ending Dec 31, 2025, and +7.2% a year over ten years. Past performance does not guarantee future results.
Who manages RLIEX?
RLIEX is offered by Lazard through Lazard Funds Inc.